skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline
Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline
Material Type:
Artigo 		Adicionar ao Meu Espaço

Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline

Korde, Larissa A ; Somerfield, Mark R ; Carey, Lisa A ; Crews, Jennie R ; Denduluri, Neelima ; Hwang, E Shelley ; Khan, Seema A ; Loibl, Sibylle ; Morris, Elizabeth A ; Perez, Alejandra ; Regan, Meredith M ; Spears, Patricia A ; Sudheendra, Preeti K ; Symmans, W Fraser ; Yung, Rachel L ; Harvey, Brittany E ; Hershman, Dawn L

Journal of clinical oncology, 2021-05, Vol.39 (13), p.1485-1505 [Periódico revisado por pares]

United States: Wolters Kluwer Health

Texto completo disponível

Citações Citado por
2
Differential Response to Neoadjuvant Chemotherapy Among 7 Triple-Negative Breast Cancer Molecular Subtypes
Differential Response to Neoadjuvant Chemotherapy Among 7 Triple-Negative Breast Cancer Molecular Subtypes
Material Type:
Artigo 		Adicionar ao Meu Espaço

Differential Response to Neoadjuvant Chemotherapy Among 7 Triple-Negative Breast Cancer Molecular Subtypes

MASUDA, Hiroko ; BAGGERLY, Keith A ; FRASER SYMMANS, W ; UENO, Naoto T ; YING WANG ; YA ZHANG ; GONZALEZ-ANGULO, Ana Maria ; MERIC-BERNSTAM, Funda ; VALERO, Vicente ; LEHMANN, Brian D ; PIETENPOL, Jennifer A ; HORTOBAGYI, Gabriel N

Clinical cancer research, 2013-10, Vol.19 (19), p.5533-5540 [Periódico revisado por pares]

Philadelphia, PA: American Association for Cancer Research

Texto completo disponível

Citações Citado por
3
Neoadjuvant Trastuzumab Emtansine and Pertuzumab in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Three-Year Outcomes From the Phase III KRISTINE Study
Neoadjuvant Trastuzumab Emtansine and Pertuzumab in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Three-Year Outcomes From the Phase III KRISTINE Study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Neoadjuvant Trastuzumab Emtansine and Pertuzumab in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Three-Year Outcomes From the Phase III KRISTINE Study

Hurvitz, Sara A ; Martin, Miguel ; Jung, Kyung Hae ; Huang, Chiun-Sheng ; Harbeck, Nadia ; Valero, Vicente ; Stroyakovskiy, Daniil ; Wildiers, Hans ; Campone, Mario ; Boileau, Jean-François ; Fasching, Peter A ; Afenjar, Karen ; Spera, Gonzalo ; Lopez-Valverde, Vanesa ; Song, Chunyan ; Trask, Peter ; Boulet, Thomas ; Sparano, Joseph A ; Symmans, W Fraser ; Thompson, Alastair M ; Slamon, Dennis

Journal of clinical oncology, 2019-09, Vol.37 (25), p.2206-2216 [Periódico revisado por pares]

United States: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
4
Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update
Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update
Material Type:
Artigo 		Adicionar ao Meu Espaço

Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update

Allison, Kimberly H ; Hammond, M Elizabeth H ; Dowsett, Mitchell ; McKernin, Shannon E ; Carey, Lisa A ; Fitzgibbons, Patrick L ; Hayes, Daniel F ; Lakhani, Sunil R ; Chavez-MacGregor, Mariana ; Perlmutter, Jane ; Perou, Charles M ; Regan, Meredith M ; Rimm, David L ; Symmans, W Fraser ; Torlakovic, Emina E ; Varella, Leticia ; Viale, Giuseppe ; Weisberg, Tracey F ; McShane, Lisa M ; Wolff, Antonio C

Journal of clinical oncology, 2020-04, Vol.38 (12), p.1346-1366 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
5
Neoadjuvant trastuzumab, pertuzumab, and chemotherapy versus trastuzumab emtansine plus pertuzumab in patients with HER2-positive breast cancer (KRISTINE): a randomised, open-label, multicentre, phase 3 trial
Neoadjuvant trastuzumab, pertuzumab, and chemotherapy versus trastuzumab emtansine plus pertuzumab in patients with HER2-positive breast cancer (KRISTINE): a randomised, open-label, multicentre, phase 3 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Neoadjuvant trastuzumab, pertuzumab, and chemotherapy versus trastuzumab emtansine plus pertuzumab in patients with HER2-positive breast cancer (KRISTINE): a randomised, open-label, multicentre, phase 3 trial

Hurvitz, Sara A ; Martin, Miguel ; Symmans, W Fraser ; Jung, Kyung Hae ; Huang, Chiun-Sheng ; Thompson, Alastair M ; Harbeck, Nadia ; Valero, Vicente ; Stroyakovskiy, Daniil ; Wildiers, Hans ; Campone, Mario ; Boileau, Jean-François ; Beckmann, Matthias W ; Afenjar, Karen ; Fresco, Rodrigo ; Helms, Hans-Joachim ; Xu, Jin ; Lin, Yvonne G ; Sparano, Joseph ; Slamon, Dennis

The lancet oncology, 2018-01, Vol.19 (1), p.115-126 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
6
Addition of the PARP inhibitor veliparib plus carboplatin or carboplatin alone to standard neoadjuvant chemotherapy in triple-negative breast cancer (BrighTNess): a randomised, phase 3 trial
Addition of the PARP inhibitor veliparib plus carboplatin or carboplatin alone to standard neoadjuvant chemotherapy in triple-negative breast cancer (BrighTNess): a randomised, phase 3 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Addition of the PARP inhibitor veliparib plus carboplatin or carboplatin alone to standard neoadjuvant chemotherapy in triple-negative breast cancer (BrighTNess): a randomised, phase 3 trial

Loibl, Sibylle ; O'Shaughnessy, Joyce ; Untch, Michael ; Sikov, William M ; Rugo, Hope S ; McKee, Mark D ; Huober, Jens ; Golshan, Mehra ; von Minckwitz, Gunter ; Maag, David ; Sullivan, Danielle ; Wolmark, Norman ; McIntyre, Kristi ; Ponce Lorenzo, Jose J ; Metzger Filho, Otto ; Rastogi, Priya ; Symmans, W Fraser ; Liu, Xuan ; Geyer, Charles E

The lancet oncology, 2018-04, Vol.19 (4), p.497-509 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
7
Molecular Anatomy of Breast Cancer Stroma and Its Prognostic Value in Estrogen Receptor–Positive and –Negative Cancers
Molecular Anatomy of Breast Cancer Stroma and Its Prognostic Value in Estrogen Receptor–Positive and –Negative Cancers
Material Type:
Artigo 		Adicionar ao Meu Espaço

Molecular Anatomy of Breast Cancer Stroma and Its Prognostic Value in Estrogen Receptor–Positive and –Negative Cancers

Bianchini, Giampaolo ; Qi, Yuan ; Alvarez, Ricardo H ; Iwamoto, Takayuki ; Coutant, Charles ; Ibrahim, Nuhad K ; Valero, Vicente ; Cristofanilli, Massimo ; Green, Marjorie C ; Radvanyi, Laszlo ; Hatzis, Christos ; Hortobagyi, Gabriel N ; Andre, Fabrice ; Gianni, Luca ; Symmans, W Fraser ; Pusztai, Lajos

Journal of clinical oncology, 2010-10, Vol.28 (28), p.4316-4323 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
8
Measurement of Residual Breast Cancer Burden to Predict Survival After Neoadjuvant Chemotherapy
Measurement of Residual Breast Cancer Burden to Predict Survival After Neoadjuvant Chemotherapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Measurement of Residual Breast Cancer Burden to Predict Survival After Neoadjuvant Chemotherapy

FRASER SYMMANS, W ; PEINTINGER, Florentia ; BUZDAR, Aman U ; SINGLETARY, S. Eva ; HORTOBAGYI, Gabriel N ; PUSZTAI, Lajos ; HATZIS, Christos ; RAJAN, Radhika ; KUERER, Henry ; VALERO, Vicente ; ASSAD, Lina ; PONIECKA, Anna ; HENNESSY, Bryan ; GREEN, Marjorie

Journal of clinical oncology, 2007-10, Vol.25 (28), p.4414-4422 [Periódico revisado por pares]

Baltimore, MD: American Society of Clinical Oncology

Sem texto completo

Citações Citado por
9
Estrogen Receptor (ER) mRNA and ER-Related Gene Expression in Breast Cancers That Are 1% to 10% ER-Positive by Immunohistochemistry
Estrogen Receptor (ER) mRNA and ER-Related Gene Expression in Breast Cancers That Are 1% to 10% ER-Positive by Immunohistochemistry
Material Type:
Artigo 		Adicionar ao Meu Espaço

Estrogen Receptor (ER) mRNA and ER-Related Gene Expression in Breast Cancers That Are 1% to 10% ER-Positive by Immunohistochemistry

IWAMOTO, Takayuki ; BOOSER, Daniel ; MATSUOKA, Junji ; YANG, Elliana J ; HORTOBAGYI, Gabriel N ; HATZIS, Christos ; FRASER SYMMANS, W ; PUSZTAI, Lajos ; VALERO, Vicente ; MURRAY, James L ; KOENIG, Kimberly ; ESTEVA, Francisco J ; UENO, Naoto T ; JIE ZHANG ; WEIWEI SHI ; YUAN QI

Journal of clinical oncology, 2012-03, Vol.30 (7), p.729-734 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
10
Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy in Patients With Node-Positive Breast Cancer: The ACOSOG Z1071 (Alliance) Clinical Trial
Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy in Patients With Node-Positive Breast Cancer: The ACOSOG Z1071 (Alliance) Clinical Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy in Patients With Node-Positive Breast Cancer: The ACOSOG Z1071 (Alliance) Clinical Trial

Boughey, Judy C ; Suman, Vera J ; Mittendorf, Elizabeth A ; Ahrendt, Gretchen M ; Wilke, Lee G ; Taback, Bret ; Leitch, A. Marilyn ; Kuerer, Henry M ; Bowling, Monet ; Flippo-Morton, Teresa S ; Byrd, David R ; Ollila, David W ; Julian, Thomas B ; McLaughlin, Sarah A ; McCall, Linda ; Symmans, W. Fraser ; Le-Petross, Huong T ; Haffty, Bruce G ; Buchholz, Thomas A ; Nelson, Heidi ; Hunt, Kelly K

JAMA : the journal of the American Medical Association, 2013-10, Vol.310 (14), p.1455-1461 [Periódico revisado por pares]

Chicago, IL: American Medical Association

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (421)
  2. Revistas revisadas por pares (419)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (451)
  2. Book Chapters  (11)
  3. Conjunto de Dados  (5)
  4. Imagens  (4)
  5. Web Resources  (2)
  6. Reports  (1)
  7. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1998  (13)
  2. 1998Até2003  (43)
  3. 2004Até2009  (80)
  4. 2010Até2016  (123)
  5. Após 2016  (209)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.